Aaa Pharmatrade Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 0.55 M
- Company Age 16 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 3.39 Cr
- Revenue Growth -3.32%
- Profit Growth -4.58%
- Ebitda 1.58%
- Net Worth 37.50%
- Total Assets 32.31%
About Aaa Pharmatrade
Aaa Pharmatrade Private Limited (APPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 April 2008 and has a history of 16 years and ten months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.55 M.
The company currently has active open charges totaling ₹3.39 Cr.
Amit Khanna, Ankit Khanna, and Pratibha Khanna serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U74120DL2008PTC176178
- Company No.
176178
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Aaa Pharmatrade?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Amit Khanna  | Director | 01-Apr-2008 | Current |
| Ankit Khanna | Director | 01-Jul-2021 | Current |
| Pratibha Khanna | Director | 01-Apr-2008 | Current |
Financial Performance of Aaa Pharmatrade.
Aaa Pharmatrade Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 3.32% decrease. The company also saw a slight decrease in profitability, with a 4.58% decrease in profit. The company's net worth Soared by an impressive increase of 37.5%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aaa Pharmatrade?
In 2023, Aaa Pharmatrade had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹33.91 M
₹0
Charges Breakdown by Lending Institutions
- Others : 3.29 Cr
- Hdfc Bank Limited : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Aug 2021 | Hdfc Bank Limited | ₹1.01 M | Open |
| 21 May 2021 | Others | ₹3.29 Cr | Open |
How Many Employees Work at Aaa Pharmatrade?
Aaa Pharmatrade has a workforce of 81 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aaa Pharmatrade, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aaa Pharmatrade's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
